Navigation Links
Generex Announces Publication on Application of Antigen Express Technology for Early Detection of Type 1 Diabetes
Date:5/3/2011

WORCESTER, Mass. and TORONTO, May 3, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced publication of results of studies applicable to the early diagnosis, and possibly treatment of, Type 1 diabetes.  The study, entitled: "Recognition of Ii-Key/MHC Class II Epitope Hybrids Derived from Proinsulin and GAD Peptides by T Cells in Type 1 Diabetes" appears in the April issue of the international peer-reviewed journal Hormone and Metabolism Research.  The article reports on the results of a collaborative study between scientists in the laboratory of Professor Paolo Pozzilli at the University Campus Bio-Medico in Rome, Italy and scientists at Generex's wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com).

(Logo: http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b)

The methodology reported in the publication for identification of autoimmune cells in diabetic patients relies upon the Ii-Key technology developed at Antigen Express.  Specifically, attaching the Ii-Key segment to an antigenic peptide designed to activate CD4+ T helper cells increases the potency of the peptide while not altering its specificity.  To date, this technology has been used successfully to increase the potency of a variety of antigenic peptides.  The most advanced Ii-Key modified peptide clinically is a HER2 peptide that is currently in a Phase II clinical trial as an immunotherapeutic vaccine for patients with breast cancer.

In the case of Type 1 diabetes, autoimmunity is directed at insulin producing cells in the pancreas; in particular, towards the proinsulin and glutamic acid decarboxylase (GAD65) proteins.  The study reports that Ii-Key modified peptides from each of these proteins were ca
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Generex Oral-lyn™ Data to be Presented at Two International Scientific Symposia
2. Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research
3. Generex Announces $3.0 Million Capital Investment
4. Generex Provides Additional Details for October 21st Live Video Webcast
5. Generex Common Stock to be Quoted on the OTCQB Under the Symbol GNBT Beginning Thursday, October 21, 2010
6. Generex Provides Additional Reverse Stock Split Information for the Consideration of Stockholders
7. Generex Scientific Advisor Weighs in on Reverse Stock Split Proposal
8. Generex Plans Rights Offering to Stockholders Following Reverse Stock Split
9. Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board
10. Generex Announces That Adjournment will be Sole Matter Considered at Special Meeting of Stockholders on September 17, 2010
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2015)... - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... discussions with certain shareholders representing approximately 45% of the ... with certain matters including the appointment of auditors at ... 26, 2015 (the "Meeting") it intends to adjourn the ... place when the Meeting reconvenes. The Meeting will be ...
(Date:3/25/2015)... IL (PRWEB) March 25, 2015 ... Symmetry® Top-Loading Balances and Analytical Balances to get ... expanded line of weighing balances from the trusted ... Toploading Balances increase your efficiency by providing ... variety of samples. Weighing modes include parts counting, ...
(Date:3/25/2015)... March 25, 2015  Point-of-Care Partners, a leading ... firm, has launched the ePrescribing State Law Capsule ... of ePrescribing regulatory requirements in all 50 states ... landscape continues to change rapidly, so we have ... industry, and ultimately patients, need," said Tony ...
(Date:3/25/2015)... HAGUE, Netherlands , March 25, 2015  EndoStim ... for chronic gastro-esophageal reflux disease (GERD) in the March ... Surgery . 2015; 157(3):556-567 ], establishing the long term ... The study included 25 patients with severe GERD ... prescribed daily proton pump inhibitor (PPI) medication for an ...
Breaking Biology Technology:SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5New Economical Top-Loading and Analytical Symmetry Balances from Cole-Parmer 2Point-of-Care Partners Launches the ePrescribing State Law Capsule 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 3
... 2011 Nile Therapeutics, Inc. (NASDAQ: ... heart failure patients, today announced that the Company,s securities will ... open of business on May 12, 2011.  The Company expects ... on the OTCQB Marketplace following the suspension of trading on ...
... MOUNTAIN VIEW, Calif., May 11, 2011 ... Biosciences (SBI) , both leaders in genetic modification technology, have ... biotechnology companies involving Transposagen,s piggyBac ™ technology. ... Genetic Modification System enables researchers ...
... 11, 2011 Novavax, Inc. (Nasdaq: NVAX ... by the Tech Council of Maryland (TCM), the largest ... communities of Maryland.  Novavax was recognized as the firm ... community and for its presence and leadership in Maryland. ...
Cached Biology Technology:Nile Therapeutics to Transition to OTCQB Marketplace 2Nile Therapeutics to Transition to OTCQB Marketplace 3Transposagen's piggyBac™ Vectors to be Distributed by System Biosciences 2Transposagen's piggyBac™ Vectors to be Distributed by System Biosciences 3Novavax Named Biotechnology Firm of the Year by Tech Council of Maryland 2
(Date:3/24/2015)... --  NexID Biometrics LLC, whose spoof-mitigation technology boosts ... the beginning of shipments of version 2.0 of its ... based in Potsdam, N.Y. , is ... began here today at the Walter E. Washington Convention ... SDK boosts the accuracy rate range to 96.5 to ...
(Date:3/23/2015)...  In the 2014 fiscal year, irs.gov recorded over ... figure accounts for a fraction of the estimated losses ... exceeds $11 billion globally. The polygraph has traditionally been ... occurred. Investor Mark Saint Juste along with ... partnered to administer the test in a new ...
(Date:3/20/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces its biometric payment ... products featured in 2015 "I Want That" International CES ... on the DIY Network.   DIY,s "I ... , site of the 2015 International CES for a ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... Barbara have made a surprising discovery: phagocytosis depends more ... far-reaching implications for immunology, vaccine development and drug delivery, ... National Academy of Sciences by Samir Mitragotri, a UCSB ... Champion. The paper will be published in print on ...
... for mice, it's one that is best made with input from ... understand the brain chemicals that guide mate selection, Pfaff and his ... alone or a male mouse with a female. The females consistently ... data suggest that female mice may use, or even copy, the ...
... of Agriculture and Life Sciences are part of consortium ... awarded $5 million from the USDA to enable routine ... disease-resistant wheat. , "For the past two decades, an ... chromosome specific DNA sequences or markers have been used ...
Cached Biology News:When mice choose mates, experience counts 2Virginia Tech helping to develop higher quality, disease-resistant wheat varieties 2
... 4300 System features Saga GT , is ... automates electrophoresis, lane finding, location of standards, ... ,Saga GT is second generation software ... initially developed at the University of Washington ...
Request Info...
We offer solid and solution phase peptide synthesis including a whole range of modifications. Please send the details of your peptide synthesis need to info@rpeptide.com...
Request Info...
Biology Products: